Refresh

ALEMBIC PHARMACEUTICALS LTD. - Press Release


Download
15 May 2017
With reference to the captioned subject, this is to inform the exchange that the Company has received U.S. Food & Drug Administration (FDA) approval for Fenofibric Acid Delayed-Release Capsules. Please find enclosed herewith our press release. We request you to kindly take the same on record.

Source: BSE India

View all announcements for ALEMBIC PHARMACEUTICALS LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com